Gabapentin Capsule
Product Images NDC 55154-7992

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55154-7992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D5ccd1ed 17ec 4f79 B838 8a10dab4179a 00

Gabapentin Capsules, USP with 100mg strength, manufactured by Alkem Laboratories Ltd in India and distributed by Ascend Laboratories LLC and Major Pharmaceuticals in the USA. It comes in a pack of 10 capsules, each containing Gabapentin 100mg. Please refer to the product insert found at www.majorpharmaceuticals.com for complete prescribing information, precautions, and warnings. Store between 20°C to 25°C (68°F to 77°F), and pharmacists are advised to dispense the medication guide to each patient. This unit dose package is not child-resistant and intended for institutional use only.*

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

This text appears to be a medical formula for calculating kidney function. It involves multiplying the weight of a patient (in kilograms) by their serum creatinine level in milligrams per deciliter (mg/dL). Female patients may have a correction factor applied by multiplying the result by 0.85.*

FDA Label Image

Gabapentin Fig1

The text describes a study on the effectiveness of a medication in reducing pain. It includes a mean pain score of 10 and a chart showing a 4-week dose titration period and a 4-week fixed dose period with placebo and Gabapentin, 3600 mg/day. It also mentions a baseline 1.*

FDA Label Image

Gabapentin Fig2

This appears to be a table showing the mean pain score for participants in a study over a period of weeks. Different doses of Gabapentin (1800mg/day and 2400mg/day) are compared to a placebo. There are two periods in the study, a dose titration period and a fixed dose period. However, without further context or information, it is difficult to provide a more detailed description or analysis.*

FDA Label Image

Gabapentin Fig3

The text represents a graph that illustrates the proportion of responders in controlled studies for a medical condition called PHN. The graph shows the percentage of patients with a reduction in pain score from 10% to 100%. The data is broken down for different treatment groups, and there is a key denoting significance levels of p < 0.001. The also captures various currency amounts but it is not clear how these relate to the graph.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

FDA Label Image

Gabapentin-struc (Gabapentin Struc)

FDA Label Image

Image 01

Gabapentin Capsules, USP, 300mg is a prescription medication. It comes in a pack containing 10 capsules with 300mg of Gabapentin. The medicine is manufactured by Alkem Laboratories Ltd, Mumbai, India and is distributed in the USA by MAJOR® PHARMACEUTICALS, Livonia, MI, and Cardinal Health, Dublin, OH. It is recommended that the medication be stored in a cool place, and it is advised to consult a doctor before use. More information, such as the complete prescribing information, precautions, and warning, can be found in the medication guide.*

FDA Label Image

Image 02

This is a description of Gabapentin capsules, 400mg which are sold in a pack of 10. It has information about dosage, storage, and precautions which are included in the product insert. It is only intended for institutional use and should be kept out of the reach of children. It is manufactured by Alkem Laboratories in Mumbai and distributed by Ascend Laboratories, Major Pharmaceuticals, and Cardinal Health.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.